These results demonstrate that, despite a wide variation in the frequencies of ameloblastomas harboring BRAF V600E mutations are observed in different studies, the overall prevalence of this mutation is relatively high in Latin American samples. This evidence concerns the gene BRAF and ameloblastoma.